Delivery Order SPE2DX15D2205-SPE2DX23F80PY
- Not listed
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $20,558.53, is a Firm Fixed Price Delivery Order for the supply of DIOVAN HCT 160-25 MG TABLET 90S, a cardiovascular medication. The contract is not designated as a set-aside and was competitively awarded. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop...
- This federal contract award is a delivery order worth $25,873.13 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the provision of DIOVAN HCT 160-12.5 MG tablets, a cardiovascular medication, with a completion date of November 13, 2024. This contract is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which serves as a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,713.41 firm fixed-price delivery order contract is for the supply of DIOVAN HCT 160-25 MG tablets, with a period of performance through March 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This federal contract award, valued at $11,712.89, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a potential value of $999,999,999 and runs through November 2026. The contract is for the delivery of DIOVAN HCT 160-25 MG TABLET 90S, a cardiovascular medication. There is no...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,061.54 fixed-price delivery order is for the supply of DIOVAN HCT 320-25 MG TABLET 90S, a cardiovascular medication. The contract has an ultimate completion date of December 9, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,409.25 firm fixed-price delivery order is for the supply of DIOVAN HCT 160-25 MG TABLET 90S, a cardiovascular medication. The contract has a completion date of March 18, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- This federal contract award, valued at $1,092.69, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a pharmaceutical distribution company owned by the parent company Cencora, Inc. The contract is a delivery order for 4558880765 DIOVAN HCT 160-25 MG TABLET 90S, a cardiovascular medication. The award has an ultimate completion date of October 26, 2022 and is a firm fixed-price contract. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp...
- This federal contract award, valued at $30,809.22, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the procurement of DIOVAN HCT 320-12.5 MG TAB 90S, a cardiovascular medication. The award has an ultimate completion date of May 30, 2024 and utilizes a Firm Fixed Price pricing type. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,422.92 firm-fixed-price delivery order is for the supply of DIOVAN HCT 160-25 MG TABLET 90S, a cardiovascular medication. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $38,200.86, is a delivery order for the supply of Diovan HCT 160-12.5 mg tablets. The contract has an ultimate completion date of December 16, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- SPE2DX15D2205Indefinite Delivery Contract
- SPE2DX15D2205-SPE2DX23F80PYDelivery Order
This is a federal contract award issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $46,429.91, is a delivery order for DIOVAN HCT 160-25 MG TABLET 90S, a cardiovascular medication. The award is not associated with a set-aside program and is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. Amerisourcebergen also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $46.4k | 4/26/23 |